64 related articles for article (PubMed ID: 26708423)
21. Genomic Characterization of Differentiated Thyroid Carcinoma.
Song YS; Park YJ
Endocrinol Metab (Seoul); 2019 Mar; 34(1):1-10. PubMed ID: 30912334
[TBL] [Abstract][Full Text] [Related]
22. Papillary Thyroid Cancer: Genetic Alterations and Molecular Biomarker Investigations.
Abdullah MI; Junit SM; Ng KL; Jayapalan JJ; Karikalan B; Hashim OH
Int J Med Sci; 2019; 16(3):450-460. PubMed ID: 30911279
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-146b-3p Promotes Cell Metastasis by Directly Targeting
Yu C; Zhang L; Luo D; Yan F; Liu J; Shao S; Zhao L; Jin T; Zhao J; Gao L
Thyroid; 2018 Dec; 28(12):1627-1641. PubMed ID: 30244634
[No Abstract] [Full Text] [Related]
24. Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis.
Liang W; Sun F
J Endocrinol Invest; 2018 Oct; 41(10):1237-1245. PubMed ID: 29520684
[TBL] [Abstract][Full Text] [Related]
25. MicroRNA-based molecular classification of papillary thyroid carcinoma.
Rosignolo F; Memeo L; Monzani F; Colarossi C; Pecce V; Verrienti A; Durante C; Grani G; Lamartina L; Forte S; Martinetti D; Giuffrida D; Russo D; Basolo F; Filetti S; Sponziello M
Int J Oncol; 2017 May; 50(5):1767-1777. PubMed ID: 28393181
[TBL] [Abstract][Full Text] [Related]
26. Targeted next-generation sequencing for TP53, RAS, BRAF, ALK and NF1 mutations in anaplastic thyroid cancer.
Latteyer S; Tiedje V; König K; Ting S; Heukamp LC; Meder L; Schmid KW; Führer D; Moeller LC
Endocrine; 2016 Dec; 54(3):733-741. PubMed ID: 27696251
[TBL] [Abstract][Full Text] [Related]
27. MiRNA-146b-5p upregulates migration and invasion of different Papillary Thyroid Carcinoma cells.
Lima CR; Geraldo MV; Fuziwara CS; Kimura ET; Santos MF
BMC Cancer; 2016 Feb; 16():108. PubMed ID: 26883911
[TBL] [Abstract][Full Text] [Related]
28. Integrated transcriptome sequencing and weighted gene co-expression network analysis reveals key genes of papillary thyroid carcinomas.
Pan L; Zhang L; Fu J; Shen K; Zhang G
Heliyon; 2024 Apr; 10(7):e27928. PubMed ID: 38560266
[TBL] [Abstract][Full Text] [Related]
29. Identification of key biomarkers for thyroid cancer by integrative gene expression profiles.
Tian J; Bai Y; Liu A; Luo B
Exp Biol Med (Maywood); 2021 Jul; 246(14):1617-1625. PubMed ID: 33899546
[TBL] [Abstract][Full Text] [Related]
30. Exploration of the Potential Biomarkers of Papillary Thyroid Cancer (PTC) Based on RT
Peng Y; Zhang HW; Cao WH; Mao Y; Cheng RC
Cancer Manag Res; 2020; 12():9235-9246. PubMed ID: 33061614
[TBL] [Abstract][Full Text] [Related]
31. Integrated bioinformatics analysis of the association between apolipoprotein E expression and patient prognosis in papillary thyroid carcinoma.
Jiang Q; Feng W; Xiong C; Lv Y
Oncol Lett; 2020 Mar; 19(3):2295-2305. PubMed ID: 32194729
[TBL] [Abstract][Full Text] [Related]
32. Analysis of lncRNA and mRNA Transcriptomes Expression in Thyroid Cancer Tissues Among Patients With Exposure of Medical Occupational Radiation.
Shi F; Liu Y; Li M; Wen P; Qian QQ; Fan Y; Huang R
Dose Response; 2019; 17(3):1559325819864223. PubMed ID: 31384241
[TBL] [Abstract][Full Text] [Related]
33. miR-650 promotes motility of anaplastic thyroid cancer cells by targeting PPP2CA.
Orlandella FM; Mariniello RM; Iervolino PLC; Imperlini E; Mandola A; Verde A; De Stefano AE; Pane K; Franzese M; Esposito S; Basolo F; Orrù S; Salvatore G
Endocrine; 2019 Sep; 65(3):582-594. PubMed ID: 30927143
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma.
Feng G; Ma HM; Huang HB; Li YW; Zhang P; Huang JJ; Cheng L; Li GR
Cancer Manag Res; 2019; 11():1263-1274. PubMed ID: 30799953
[TBL] [Abstract][Full Text] [Related]
35. Network Analyses of Integrated Differentially Expressed Genes in Papillary Thyroid Carcinoma to Identify Characteristic Genes.
Shang J; Ding Q; Yuan S; Liu JX; Li F; Zhang H
Genes (Basel); 2019 Jan; 10(1):. PubMed ID: 30646607
[TBL] [Abstract][Full Text] [Related]
36. Identification of key genes and miRNAs markers of papillary thyroid cancer.
Qiu J; Zhang W; Zang C; Liu X; Liu F; Ge R; Sun Y; Xia Q
Biol Res; 2018 Nov; 51(1):45. PubMed ID: 30414611
[TBL] [Abstract][Full Text] [Related]
37. Meta-analysis of microarray datasets identify several chromosome segregation-related cancer/testis genes potentially contributing to anaplastic thyroid carcinoma.
Liu M; Qiu YL; Jin T; Zhou Y; Mao ZY; Zhang YJ
PeerJ; 2018; 6():e5822. PubMed ID: 30386706
[TBL] [Abstract][Full Text] [Related]
38. Genetic expression profile-based screening of genes and pathways associated with papillary thyroid carcinoma.
Li S; Yin Y; Yu H
Oncol Lett; 2018 Nov; 16(5):5723-5732. PubMed ID: 30344727
[TBL] [Abstract][Full Text] [Related]
39. Identification of potential functional genes in papillary thyroid cancer by co-expression network analysis.
Ao ZX; Chen YC; Lu JM; Shen J; Peng LP; Lin X; Peng C; Zeng CP; Wang XF; Zhou R; Chen Z; Xiao HM; Deng HW
Oncol Lett; 2018 Oct; 16(4):4871-4878. PubMed ID: 30250553
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
